- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus Type 2 Without Complication in South Africa
Total 898 results
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Taiwan, Australia, Hungary, Germany, India, Canada, Spain, Czechia, Argentina, Poland, Colombia, South Africa, France, Greece, Romania
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Colombia, Russian Federation, Germany, Hungary, Italy, Mexico, Peru, Romania, Slovakia, Brazil, El Salvador
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, Chile, Czech Republic, India, Peru, Poland
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyNot yet recruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Intarcia TherapeuticsCompleted
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
PhaseBio Pharmaceuticals Inc.Completed
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
GlaxoSmithKlineDuke Clinical Research InstituteCompletedDiabetes MellitusUnited States, Argentina, Germany, Poland, Russian Federation, Spain, Taiwan, Czechia, Hungary, Italy, Ukraine, Belgium, Netherlands, South Africa, Sweden, Thailand, Korea, Republic of, Mexico, Bulgaria, Hong Kong, Peru, Philippines, Gree... and more
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
PfizerCompletedDiabetes Mellitus, Type 2 | NIDDMUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, Italy, Korea, Republic of, Russian Federation, South Africa, United Kingdom, Vietnam, Philippines, Malaysia, Estonia, Latvia, Lithuania, Poland, Finland, Canada, Hong Kong, Argentina, Hun... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Spain, Hungary, Mexico, Argentina, Slovakia, Greece, South Africa, Australia
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Hungary, Slovakia
-
Medical University of South CarolinaWeight Watchers InternationalCompletedObesity | Overweight | Type 2 DiabetesUnited States
-
Elcelyx Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusUnited States
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Italy, Latvia, Mexico, Russian Federation, Slovakia, Spain, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Harokopio UniversityNational and Kapodistrian University of Athens; Technische Universität Dresden and other collaboratorsUnknown
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Mexico, Japan, India, Puerto Rico, China